Abstract IA041: Proteomic analyses of cancer models to identify and validate molecular determinants of health disparities
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy that remains refractory to current therapies due in part to adaptive mechanisms of therapeutic resistance and subtype plasticity. Significant racial disparities further complicate PDAC outcomes, as Black patients exhibit higher incidence rates and...